open access

Vol 52, No 6 (2021)
Original research article
Submitted: 2021-09-15
Accepted: 2021-09-15
Get Citation

Ferritin and transferrin saturation cannot be used to diagnose iron-deficiency anemia in critically ill patients

Piotr F. Czempik1, Michał P. Pluta1, Łukasz J. Krzych1
DOI: 10.5603/AHP.2021.0091
·
Acta Haematol Pol 2021;52(6):566-570.
Affiliations
  1. Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

open access

Vol 52, No 6 (2021)
ORIGINAL RESEARCH ARTICLE
Submitted: 2021-09-15
Accepted: 2021-09-15

Abstract

Abstract Introduction: Iron-deficiency anaemia (IDA) is the most common anaemia globally. The frequency of IDA among critically ill patients is not known. The aim of our study was to analyse performance of standard iron metabolism parameters in diagnosis of IDA in the critically ill. Material and methods: We performed a retrospective analysis of consecutive anaemic patients admitted to the intensive care unit. Based on various cut-off values for ferritin and/or transferrin saturation (TfS), we determined the incidence of IDA. Results: The population consisted of 27 (53%) men and 24 (47%) women. The median haemoglobin concentration was well 96 [interquartile range (IQR 87–109)] g/L. The studied population had markedly increased concentration of C-reactive protein [119 (IQR 44–196) mg/L], ferritin [686 (385–1114) µg/L], whereas iron concentration and TfS were below reference value. Depending on cut-off value chosen, IDA could be diagnosed in between 7.8 (ferritin < 100 µg/L +TfS < 20%) and 56.9 % (TfS < 20%) of patients. Conclusions: Ferritin and transferrin saturation cannot be used for precise diagnosis of IDA caused by absolute or functional iron deficiency in the critically ill.

Abstract

Abstract Introduction: Iron-deficiency anaemia (IDA) is the most common anaemia globally. The frequency of IDA among critically ill patients is not known. The aim of our study was to analyse performance of standard iron metabolism parameters in diagnosis of IDA in the critically ill. Material and methods: We performed a retrospective analysis of consecutive anaemic patients admitted to the intensive care unit. Based on various cut-off values for ferritin and/or transferrin saturation (TfS), we determined the incidence of IDA. Results: The population consisted of 27 (53%) men and 24 (47%) women. The median haemoglobin concentration was well 96 [interquartile range (IQR 87–109)] g/L. The studied population had markedly increased concentration of C-reactive protein [119 (IQR 44–196) mg/L], ferritin [686 (385–1114) µg/L], whereas iron concentration and TfS were below reference value. Depending on cut-off value chosen, IDA could be diagnosed in between 7.8 (ferritin < 100 µg/L +TfS < 20%) and 56.9 % (TfS < 20%) of patients. Conclusions: Ferritin and transferrin saturation cannot be used for precise diagnosis of IDA caused by absolute or functional iron deficiency in the critically ill.

Get Citation

Keywords

ferritin, intensive care unit, iron-deficiency anaemia, transferrin saturation

About this article
Title

Ferritin and transferrin saturation cannot be used to diagnose iron-deficiency anemia in critically ill patients

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 6 (2021)

Article type

Original research article

Pages

566-570

Page views

3780

Article views/downloads

302

DOI

10.5603/AHP.2021.0091

Bibliographic record

Acta Haematol Pol 2021;52(6):566-570.

Keywords

ferritin
intensive care unit
iron-deficiency anaemia
transferrin saturation

Authors

Piotr F. Czempik
Michał P. Pluta
Łukasz J. Krzych

References (28)
  1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5): 615–624.
  2. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill — current clinical practice in the United States. Crit Care Med. 2004; 32(1): 39–52.
  3. Thomas J, Jensen L, Nahirniak S, et al. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Heart Lung. 2010; 39(3): 217–225.
  4. Lyon AW, Chin AC, Slotsve GA, et al. Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med. 2013; 43(2): 84–90.
  5. Chornenki NLJ, James TE, Barty R, et al. Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study. Transfusion. 2020; 60(2): 256–61.
  6. Uscinska E, Sobkowicz B, Sawicki R, et al. Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency? Intern Emerg Med. 2015; 10(3): 337–344.
  7. Meybohm P, Richards T, Isbister J, et al. Patient blood management bundles to facilitate implementation. Transfus Med Rev. 2017; 31(1): 62–71.
  8. Clark SF, Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008; 23(2): 128–141.
  9. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017; 72(2): 233–247.
  10. Czempik P, Czepczor K, Czok M, et al. Simplified diagnostic algorithm for classification of preoperative anaemia based on complete blood count and its application in elective gastrointestinal surgery. Pol Przegl Chir. 2019; 91(4): 24–28.
  11. Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015; 102(6): 1585–1594.
  12. Prakash D. Anemia in the ICU: anemia of chronic disease versus anemia of acute illness. Crit Care Clin. 2012; 28(3): 333–43, v.
  13. Patteril MV, Davey-Quinn AP, Gedney JA, et al. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care. 2001; 29(5): 473–478.
  14. Fernandez R, Tubau I, Masip J, et al. Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology. 2010; 112(5): 1211–1215.
  15. Thomas DW, Hinchliffe RF, Briggs C, et al. British Committee for Standards in Haematology. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013; 161(5): 639–648.
  16. Cullis J, Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol. 2011; 154(3): 289–300.
  17. Fraenkel PG. Anemia of inflammation: a review. Med Clin North Am. 2017; 101(2): 285–296.
  18. Ratcliffe LEK, Thomas W, Glen J, et al. Diagnosis and management of iron deficiency in CKD: a summary of the NICE guideline recommendations and their rationale. Am J Kidney Dis. 2016; 67(4): 548–558.
  19. Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018; 2018: 9394060.
  20. von Haehling S, Ebner N, Evertz R, et al. Iron deficiency in heart failure: an overview. JACC Heart Fail. 2019; 7(1): 36–46.
  21. Brugnara C, Adamson J, Auerbach M, et al. Iron deficiency: what are the future trends in diagnostics and therapeutics? Clin Chem. 2013; 59(5): 740–745.
  22. Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev. 2017; 31(4): 225–233.
  23. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006; 1 Suppl 1: S4–S8.
  24. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol. 2016; 38(Suppl 1): 123–32.
  25. Heming N, Montravers P, Lasocki S. Iron deficiency in critically ill patients: highlighting the role of hepcidin. Crit Care. 2011; 15(2): 210.
  26. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93(4): 1721–1741.
  27. Lasocki S, Longrois D, Montravers P, et al. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 2011; 114(3): 688–694.
  28. Litton E, Baker S, Erber W, et al. IRONMAN Study investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study. J Intensive Care. 2018; 6: 60.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl